Thousands of Canadian breast cancer patients could avoid chemo, according to study

Results are expected to spare patients from having to undergo rounds of chemotherapy

Lisa Freedman, who is now cancer-free, poses for a photo outside her Toronto home on Friday, June 8, 2018. (Tijana Martin/The Canadian Press)

When Lisa Freedman was diagnosed with breast cancer, a genetic test of her tumour suggested chemotherapy would have no effect on the risk of recurrence, allowing her to safely skip the treatment and its dreaded side-effects.

“When the test came back, it showed that I would have a 13-per-cent chance of recurrence if I had chemo and a 12-per-cent chance if I didn’t have chemo,” said the Toronto lawyer, 61.

“So that became an easy no-chemo decision,” said Freedman, who has been cancer-free for two years.

A recently published U.S.-led study of more than 10,000 women whose tumours were tested determined that most patients with early-stage estrogen-positive breast cancer and no lymph-node spread should be able to avoid chemo and be treated with surgery, radiation and a hormone-blocking drug like tamoxifen alone.

The study is the largest ever performed looking at breast cancer treatment, and its results are expected to spare thousands of women in Canada each year from having to undergo rounds of chemotherapy and its harsh side-effects.

Funded by the U.S. National Cancer Institute, with additional funding from the Canadian Cancer Society Research Institute, the research looked at women with breast cancer with an intermediate risk of recurrence, based on their scores from the genetic test.

READ MORE: Centre gives breast cancer patients new outlook on life

Previously, scores from the US$3,000 Oncotype DX test, used since 2004, allowed doctors to sort out women at high risk and low risk of recurrence to determine whether they would benefit from chemotherapy.

But women with in-between scores fell into a grey area — should they get chemo or not?

That’s what the study, which began in 2006 and included 10,253 women aged 18 to 75, set out to determine, with participants randomized to receive chemo plus a hormone-dampening drug or that medication alone.

The results were stunning.

After nine years, the findings put the women virtually in a dead heat: more than 90 per cent of those in both groups were still alive, while almost 85 per cent in each were free of recurrence.

Researchers concluded that almost 70 per cent of women with this form of breast cancer could safely dodge chemotherapy.

“(For) women in-between, where there was some uncertainty, I think this study is very reassuring that for the majority of them we don’t have to give chemotherapy,” said Dr. Andrea Eisen, an oncologist at Sunnybrook Health Sciences Centre in Toronto, where 56 patients took part in the multi-centre trial.

The results represent an evolution in how this most common form of breast cancer will be treated in the future, agreed Dr. David Cescon, a breast medical oncologist and researcher at the Princess Margaret Cancer Centre.

“There have been other studies that have contributed, other supportive information along these lines, which have allowed us to avoid chemotherapy, particularly for women in the lower end of this middle-risk group,” he said.

“But this will allow us to make those recommendations with more confidence, particularly in the higher end of the middle range for older women.”

For Freedman, being told she didn’t need chemo was welcome news, though she admitted that the time from diagnosis to having a surgical lumpectomy and the tumour test moved so quickly, she ”never had to go through that whole angst.”

Still, she was well aware of the horrors of chemo and had wondered how she would be able to work through the treatment regimen.

“I kind of visualized myself lying on the floor in the bathroom throwing up, with my hair falling out and trying to get my strength back,” Freedman said.

“So when (the oncologist) said there was absolutely no need for chemo, it was a sigh of relief, almost tears of relief.”

Eisen said there has been an ongoing shift over the decades in how breast cancer is treated.

“Everybody used to have a mastectomy, then we realized doing a lumpectomy and radiation was essentially just as good,” she said.

“And then everybody used to have an ancillary lymph-node dissection, so removal of a lot of lymph nodes under the arm. And then we realized that a smaller operation called a sentinel node biopsy could give in most cases equivalent information.

“So now this is the first time we’re really looking at drug treatment … That’s kind of a signal of how good the outcomes are becoming, that we’d look at taking away treatment, rather than giving more.”

Sheryl Ubelacker, The Canadian Press

Just Posted

Tools for Schools program in need of school supplies for students

Supplies will be donated to students across Central Alberta

Smiles Thru Lindsey Foundation hosting a drive-in movie fundraiser

Excitement building as the big event draws closer

Expansions rolling ahead at Red Deer Hospice

Six new rooms will provide care to 100 additional residents each year

Red Deer RCMP warn public about online job scams

Red Deer man applied for a construction job and was asked a fee to process his application

Central Alberta Buccaneers come up short against Monarchs

Bucs’ lose star quarterback in heartbreaking affair

Average Canadian family spends 43% of income on taxes: study

Fraser Institute’s consumer report shows taxes accounting for larger chunk of income each year

Judge OKs Weinstein suit, cites casting couch’s history

Actress Kadian Noble can sue disgraced Hollywood mogul for violating sex trafficking laws

Employers to raise salaries 2.6% on average next year: report

Firm points to factors such possibility of more trade protectionism, rising interest rates

Lacombe Council passes second reading of cannabis bylaw

Public hearing sees opposition to bylaw; third reading coming Sept. 10th

UPDATED: Cars plunge in Italian highway bridge collapse; 25 killed

Five more people are injured and in serious condition

Court hearing on Humboldt Broncos fundraising to test Saskatchewan law

The money has yet to be distributed because Saskatchewan has legislation known as the Informal Public Appeals Act

Fredericton police release scene of shooting spree, but ‘damage’ remains

Residents of a Fredericton apartment complex may not be able to return home just yet

Bus crash in Ecuador kills 23 people, injures 14

The bus hit another vehicle in an area known as dead man’s curve on Tuesday

Trump and Omarosa spar over claim he used N-word

Manigault Newman continues promoting her White House tell-all and releasing secret audio recordings

Most Read